Trial Outcomes & Findings for Low-level Laser Therapy in Patients With Chronic Fibromyalgia (NCT NCT02948634)

NCT ID: NCT02948634

Last Updated: 2020-03-03

Results Overview

Self-Report Questionnaire containing 21 questions, maximum/worse score=100; minimum/best score=0.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

28 participants

Primary outcome timeframe

baseline, 1 week, and 1 month after treatment

Results posted on

2020-03-03

Participant Flow

Participant milestones

Participant milestones
Measure
Sham Phoenix Laser Treatment
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
Active Phoenix Laser Treatment
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes. Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
Overall Study
STARTED
17
11
Overall Study
COMPLETED
7
9
Overall Study
NOT COMPLETED
10
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Sham Phoenix Laser Treatment
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
Active Phoenix Laser Treatment
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes. Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
Overall Study
Lack of efficacy and study suspended
10
2

Baseline Characteristics

Low-level Laser Therapy in Patients With Chronic Fibromyalgia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Sham Phoenix Laser Treatment
n=17 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
Active Phoenix Laser Treatment
n=11 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes. Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
Total
n=28 Participants
Total of all reporting groups
Age, Continuous
53.0 years
STANDARD_DEVIATION 10.3 • n=99 Participants
53.0 years
STANDARD_DEVIATION 10.2 • n=107 Participants
53.0 years
STANDARD_DEVIATION 10.2 • n=206 Participants
Sex: Female, Male
Female
17 Participants
n=99 Participants
11 Participants
n=107 Participants
28 Participants
n=206 Participants
Sex: Female, Male
Male
0 Participants
n=99 Participants
0 Participants
n=107 Participants
0 Participants
n=206 Participants
Race/Ethnicity, Customized
% white
75 percent
n=99 Participants
75 percent
n=107 Participants
75 percent
n=206 Participants
Race/Ethnicity, Customized
% black
25 percent
n=99 Participants
25 percent
n=107 Participants
25 percent
n=206 Participants
Revised Symptom Impact Questionnaire
62.0 units on a scale
STANDARD_DEVIATION 7.6 • n=99 Participants
68.3 units on a scale
STANDARD_DEVIATION 14.8 • n=107 Participants
65.7 units on a scale
STANDARD_DEVIATION 12.5 • n=206 Participants

PRIMARY outcome

Timeframe: baseline, 1 week, and 1 month after treatment

Self-Report Questionnaire containing 21 questions, maximum/worse score=100; minimum/best score=0.

Outcome measures

Outcome measures
Measure
Sham Phoenix Laser Treatment
n=7 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
Active Phoenix Laser Treatment
n=9 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes. Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
The Revised Symptom Impact Questionnaire
Baseline
62.0 score on a scale
Standard Deviation 7.6
68.3 score on a scale
Standard Deviation 14.8
The Revised Symptom Impact Questionnaire
1 week
47.1 score on a scale
Standard Deviation 21.8
50.5 score on a scale
Standard Deviation 22.5
The Revised Symptom Impact Questionnaire
1 month
45.8 score on a scale
Standard Deviation 22.5
50.2 score on a scale
Standard Deviation 25.3

SECONDARY outcome

Timeframe: baseline, 1 week, and 1 month after treatment

Pain Domain: 2 Questions, 0 minimum/worse score, 100 maximum/best score

Outcome measures

Outcome measures
Measure
Sham Phoenix Laser Treatment
n=7 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
Active Phoenix Laser Treatment
n=9 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes. Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
RAND 36-Item Health Survey
Baseline
27.2 score on a scale
Standard Deviation 13.0
27.2 score on a scale
Standard Deviation 15.2
RAND 36-Item Health Survey
1 week
33.6 score on a scale
Standard Deviation 2.7
37.8 score on a scale
Standard Deviation 20.6
RAND 36-Item Health Survey
1 month
41.8 score on a scale
Standard Deviation 5.5
36.4 score on a scale
Standard Deviation 22.6

SECONDARY outcome

Timeframe: 1 week and 1 month after treatment

Self report tool describing the degree of change since baseline. Minimum/worse value is -7. Maximum/best value is +7.

Outcome measures

Outcome measures
Measure
Sham Phoenix Laser Treatment
n=7 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Sham Phoenix Laser Treatment: Sham treatment will be delivered via the same protocol in terms of time, application, and areas of treatment as stated above, except the laser unit will not discharge any photonic energy. Intervention will take place in the therapy room at the McDermott Center for Pain Management, which is appropriately equipped for laser administration. Application of therapeutic laser will be completed by licensed physical therapists who have completed safety training for therapeutic laser application including appropriate use of safety eyewear, room access, laser signage for laser use, and patient monitoring.
Active Phoenix Laser Treatment
n=9 Participants
Each participant will receive a series of nine active laser or sham treatments on a M-W-F schedule over the three week treatment period. Participants in the laser treatment group will be treated at 42 watts for up to 60 seconds at tender spots in the spine or extremities. Total treatment time is not to exceed 30 minutes. Active Phoenix Laser Treatment: The 30 min treatments will include multiple 60 sec applications to all tender points on the spine or extremities and a 10 minute application along the bilateral sympathetic ganglion in the paraspinous region. The treatment will be applied via a non-contact method, with the laser applicator held 12-18 inches above the participant's skin.
Global Rating of Change Scale
1 week
0.4 score on a scale
Standard Deviation 3.3
2.8 score on a scale
Standard Deviation 2.0
Global Rating of Change Scale
1 month
0 score on a scale
Standard Deviation 3.1
1.3 score on a scale
Standard Deviation 3.9

Adverse Events

Sham Phoenix Laser Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Active Phoenix Laser Treatment

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jason Zafereo

UT Southwestern

Phone: 14-648-1002

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place